Ewing Sarcoma Survivors Experience Elevated Long-Term Health and Mortality Risks

Among Ewing sarcoma (EWS) survivors, rates of late mortality, subsequent malignant neoplasms (SMNs), and certain chronic health conditions (CHCs) do not significantly differ between 2 chemotherapy regimens, according to research published in Cancer.

Read more: https://www.cancertherapyadvisor.com/news/ewing-sarcoma-survivors-elevated-long-term-health-mortality-risks/